Elotuzumab: Uses, Dosage, and Side Effects Overview

Summary of Key Points

Elotuzumab is a medication used to treat certain blood cancers, including multiple myeloma. It works by boosting the immune system’s ability to recognize and destroy cancer cells. Elotuzumab is typically administered as an intravenous (IV) infusion in combination with other medications. Common Elotuzumab side effects include fatigue, fever, and infusion-related reactions. Always consult your healthcare provider before starting or adjusting any medication. For personalized care, consider scheduling a telemedicine visit with one of our providers.

Names of the Medication

US Brand Name: Empliciti

Generic Name: Elotuzumab

The generic name, Elotuzumab, refers to the active ingredient in the medication, while the brand name, Empliciti, is the name given by the manufacturer.

Pharmacologic Category

1. Monoclonal Antibody
2. Immunostimulant

Elotuzumab Dosage

Elotuzumab is approved for use in adults with specific conditions. Below are the dosing guidelines for Elotuzumab treatment:

Multiple Myeloma

Combination with Lenalidomide and Dexamethasone: 10 mg/kg IV on days 1, 8, 15, and 22 of a 28-day cycle for the first two cycles, followed by administration every two weeks thereafter.

Combination with Pomalidomide and Dexamethasone: 10 mg/kg IV on days 1 and 8 of a 28-day cycle.

Other Conditions Under Investigation

Elotuzumab is being studied for its potential to treat other conditions, including amyloidosis, Waldenström’s macroglobulinemia, lymphoma, leukemia, plasma cell neoplasm, bone marrow disorders, hematologic malignancies, and myeloproliferative neoplasms. However, specific dosing guidelines for these conditions have not yet been established. Always consult your healthcare provider for the most current information on Elotuzumab for cancer treatment.

It is crucial to follow your doctor’s instructions carefully and avoid making any changes to your dose without medical guidance. If you have questions about your dosing schedule, you can schedule a telemedicine appointment with one of our providers for assistance.

Dosage Forms and Strengths

Elotuzumab is available in the following dosage forms:

1. Injection, intravenous (IV) solution: 300 mg/15 mL
2. Injection, intravenous (IV) solution: 400 mg/20 mL

Elotuzumab Administration Guidelines

Elotuzumab is administered as an intravenous (IV) infusion, delivered directly into a vein. This procedure is typically performed in a clinical setting, such as a hospital or infusion center, under the supervision of a healthcare provider. The first dose may take longer to administer, and you will be closely monitored for any reactions during and after the infusion. If the medication is well-tolerated, subsequent doses may be given more quickly.

Adverse Reactions and Side Effects

Like all medications, Elotuzumab can cause side effects. It’s important to be aware of potential reactions and to consult your healthcare provider if you experience any of the following:

1. Fatigue: Feeling unusually tired or weak is a common side effect. This may improve as your body adjusts to the treatment.
2. Fever: A mild to moderate fever may occur, particularly after the infusion.
3. Infusion Reactions: Symptoms such as chills, shortness of breath, or rash may develop during or shortly after the infusion. Your healthcare provider will monitor you closely during treatment to manage these reactions.
4. Infections: Elotuzumab can weaken your immune system, making you more susceptible to infections. Notify your doctor immediately if you develop symptoms such as a sore throat, cough, or fever.
5. Nausea: Some patients may experience nausea after receiving Elotuzumab. Anti-nausea medications can help alleviate this discomfort.

If you notice any side effects, contact your healthcare provider promptly or schedule a telemedicine visit with us for further guidance.

Contraindications

A contraindication refers to a specific condition or circumstance in which a particular treatment or medication, such as Elotuzumab, should not be used because it may pose significant risks to the patient. Understanding these contraindications is a critical step before initiating Elotuzumab therapy.

Contraindications for Elotuzumab

Hypersensitivity to Elotuzumab: If you have previously experienced a severe allergic reaction to Elotuzumab or any of its ingredients, this medication should be avoided. Signs of an allergic reaction may include a rash, swelling, difficulty breathing, or anaphylaxis—a potentially life-threatening condition that requires immediate medical attention.

Severe Infections: Elotuzumab can weaken the immune system, making it more difficult for your body to combat infections. If you are currently dealing with a serious infection, your healthcare provider may postpone treatment with Elotuzumab until the infection has been effectively treated.

Active Hepatitis B: In individuals with a history of hepatitis B, Elotuzumab may cause the virus to reactivate, potentially leading to severe liver complications. To minimize this risk, your healthcare provider will likely perform a hepatitis B screening before starting Elotuzumab therapy.

Drug-to-Drug Interactions

Elotuzumab has the potential to interact with other medications, which could either reduce its effectiveness or increase the likelihood of side effects. It is essential to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, and dietary supplements, before beginning treatment with Elotuzumab.

Medications That May Interact with Elotuzumab

Dexamethasone (Decadron): This corticosteroid is commonly used in combination with Elotuzumab for the treatment of multiple myeloma. However, it may heighten the risk of infections and other side effects, so careful monitoring is necessary.

Lenalidomide (Revlimid): Often prescribed alongside Elotuzumab, lenalidomide can also suppress the immune system, increasing vulnerability to infections. Your healthcare provider will monitor your immune function closely during treatment.

Thalidomide (Thalomid): Similar to lenalidomide, thalidomide is used in combination with Elotuzumab for multiple myeloma but may elevate the risk of blood clots and other adverse effects. Preventive measures, such as blood-thinning medications, may be recommended.

Live Vaccines: Because Elotuzumab compromises the immune system, live vaccines—such as those for measles, mumps, and rubella—should be avoided. These vaccines could potentially cause infections in individuals with weakened immunity.

Elotuzumab in Pregnancy

Is It Safe to Take Elotuzumab During Pregnancy?

There is limited information regarding the safety of Elotuzumab during pregnancy. While animal studies suggest potential risks to the developing fetus, there is insufficient data from human studies to confirm its safety. If you are pregnant or planning to become pregnant, it is crucial to discuss the potential benefits and risks with your healthcare provider. In most cases, Elotuzumab is not recommended during pregnancy unless the benefits clearly outweigh the risks.

Elotuzumab While Breastfeeding

Is It Safe to Take Elotuzumab While Breastfeeding?

It is currently unknown whether Elotuzumab passes into breast milk. Due to the possibility of serious side effects in a nursing infant, breastfeeding is generally discouraged during treatment with Elotuzumab. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore alternative options and ensure the safety of your child.

Estimated Cost of Elotuzumab

The cost of Elotuzumab can vary significantly depending on your location and insurance coverage. Without insurance, the estimated cost for a 30-day supply of Elotuzumab ranges from approximately $10,000 to $15,000 when using a GoodRx coupon. Prices may fluctuate, so it is advisable to check with your pharmacy or use a coupon service like GoodRx to find the most affordable option available to you.

Possible Alternatives

Depending on your condition, alternative medications or lifestyle adjustments may help manage your disease more effectively. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore your options in greater detail.

Multiple Myeloma

Alternative Medications: Bortezomib (Velcade), Carfilzomib (Kyprolis), and Daratumumab (Darzalex) are widely used in the treatment of multiple myeloma. These medications may complement or replace Elotuzumab, depending on your specific medical needs and treatment goals.

Lifestyle Changes: Maintaining a nutritious diet, engaging in regular physical activity, and practicing stress management techniques can support your overall health and improve your resilience during treatment.

Amyloidosis

Alternative Medications: Bortezomib (Velcade) and Cyclophosphamide (Cytoxan) are potential options for managing amyloidosis. Discuss with your doctor whether these treatments could be used alongside or as substitutes for Elotuzumab.

Lifestyle Changes: Reducing salt intake and managing blood pressure can help alleviate symptoms and enhance the effectiveness of your treatment plan.

Waldenström’s Macroglobulinemia

Alternative Medications: Rituximab (Rituxan) and Ibrutinib (Imbruvica) are commonly prescribed for Waldenström’s macroglobulinemia. These therapies may be considered if Elotuzumab is not suitable for your condition.

Lifestyle Changes: Incorporating regular exercise and a balanced diet into your routine can improve your overall well-being and support your treatment journey.

Lymphoma

Alternative Medications: Rituximab (Rituxan), Brentuximab Vedotin (Adcetris), and CHOP chemotherapy are widely used in lymphoma treatment. These options may be used in conjunction with or as alternatives to Elotuzumab therapy.

Lifestyle Changes: Avoiding smoking and limiting alcohol consumption can help support your health and improve your body’s response to treatment.

Leukemia

Alternative Medications: Imatinib (Gleevec), Dasatinib (Sprycel), and chemotherapy are commonly used to treat leukemia. These therapies may complement or replace Elotuzumab, depending on your specific diagnosis and treatment plan.

Lifestyle Changes: A nutrient-rich diet and consistent physical activity can strengthen your body during leukemia treatment and promote overall health.

Plasma Cell Neoplasm

Alternative Medications: Daratumumab (Darzalex) and Bortezomib (Velcade) are effective options for plasma cell neoplasms. These alternatives may be explored if Elotuzumab is not the best fit for your treatment plan.

Lifestyle Changes: Staying well-hydrated and adopting a healthy lifestyle can enhance your quality of life during treatment.

Bone Marrow Disorders

Alternative Medications: Lenalidomide (Revlimid) and Thalidomide (Thalomid) are frequently prescribed for bone marrow disorders. These medications may serve as alternatives to Elotuzumab, depending on your condition.

Lifestyle Changes: Regular physical activity and a balanced diet can help improve your overall health and support your treatment regimen.

Hematologic Malignancies

Alternative Medications: Chemotherapy, targeted therapies, and immunotherapies are commonly used to treat hematologic malignancies. These treatments may be used in combination with or as substitutes for Elotuzumab therapy.

Lifestyle Changes: Avoiding smoking and reducing alcohol intake can contribute to better health outcomes during treatment.

Cancer

Alternative Medications: Depending on the type of cancer, chemotherapy, radiation therapy, and immunotherapy may be considered. Elotuzumab can also be combined with these treatments to enhance effectiveness and improve outcomes.

Lifestyle Changes: Adopting a healthy diet, engaging in regular exercise, and managing stress can boost your overall health and complement your cancer treatment plan.

Myeloproliferative Neoplasms

Alternative Medications: Ruxolitinib (Jakafi) and Hydroxyurea are commonly prescribed for myeloproliferative neoplasms. These medications may be considered as alternatives to Elotuzumab, depending on your specific condition.

Lifestyle Changes: Incorporating regular exercise and a balanced diet into your daily routine can enhance your overall well-being and support your treatment.

Recent Updates on Elotuzumab Research

Recent studies are focused on improving the effectiveness of Elotuzumab when used in combination with other therapies for multiple myeloma. Researchers are exploring how Elotuzumab interacts with newer immunotherapies and targeted treatments to achieve better patient outcomes. Additionally, ongoing clinical trials are investigating its potential for treating other hematologic malignancies, such as lymphoma and leukemia.

While these findings are encouraging, further research is necessary to fully understand the range of conditions Elotuzumab can effectively treat. If you are interested in learning more about these studies, Elotuzumab administration guidelines, or opportunities to participate in clinical trials, consult your healthcare provider or schedule a telemedicine appointment with one of our specialists today.

James Kingsley

Learn More